NEW YORK, April 26 - Atlas Venture has raised $950 million from institutional investors to start a new capital fund that will invest in early-stage communications, information technology, and life science companies, the venture capital firm said Thursday.

The new fund, called Atlas Venture VI, will invest in both US and European early-stage companies, and will likely divide funding equally between the three business sectors, said a spokeswoman for Atlas Venture.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.